- Home
- CRBU vs GCTS Comparison
CRBU vs GCTS Comparison
Compare CRBU & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- GCTS
- Stock Information
- Founded
- CRBU 2011
- GCTS 1998
- Country
- CRBU United States
- GCTS United States
- Employees
- CRBU N/A
- GCTS N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- GCTS Blank Checks
- Sector
- CRBU Health Care
- GCTS Finance
- Exchange
- CRBU Nasdaq
- GCTS Nasdaq
- Market Cap
- CRBU 93.0M
- GCTS 91.7M
- IPO Year
- CRBU 2021
- GCTS N/A
- Fundamental
- Price
- CRBU $0.95
- GCTS $1.78
- Analyst Decision
- CRBU Strong Buy
- GCTS Strong Buy
- Analyst Count
- CRBU 5
- GCTS 1
- Target Price
- CRBU $11.80
- GCTS $5.00
- AVG Volume (30 Days)
- CRBU 1.0M
- GCTS 132.9K
- Earning Date
- CRBU 03-10-2025
- GCTS 03-25-2025
- Dividend Yield
- CRBU N/A
- GCTS N/A
- EPS Growth
- CRBU N/A
- GCTS N/A
- EPS
- CRBU N/A
- GCTS N/A
- Revenue
- CRBU $9,994,000.00
- GCTS $9,128,000.00
- Revenue This Year
- CRBU $3.50
- GCTS N/A
- Revenue Next Year
- CRBU $177.84
- GCTS $463.17
- P/E Ratio
- CRBU N/A
- GCTS N/A
- Revenue Growth
- CRBU N/A
- GCTS N/A
- 52 Week Low
- CRBU $0.88
- GCTS $1.55
- 52 Week High
- CRBU $5.15
- GCTS $30.52
- Technical
- Relative Strength Index (RSI)
- CRBU 40.45
- GCTS 40.62
- Support Level
- CRBU $0.88
- GCTS $1.79
- Resistance Level
- CRBU $1.01
- GCTS $2.14
- Average True Range (ATR)
- CRBU 0.08
- GCTS 0.12
- MACD
- CRBU 0.01
- GCTS -0.01
- Stochastic Oscillator
- CRBU 42.00
- GCTS 38.98
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About GCTS GCT Semiconductor Holding Inc. Common Stock
GCT Semiconductor Holding Inc. is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.